Overview

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

Status:
Terminated
Trial end date:
2016-04-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects on serum testosterone (ST) after 6 weeks of subcutaneous (SC) administration of different doses and dosing frequencies of TAK-448 to middle-aged and older men with low ST levels.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate